Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3282727 | Clinical Gastroenterology and Hepatology | 2013 | 12 Pages |
Abstract
On the basis of a meta-analysis, linaclotide improves bowel function and reduces abdominal pain and overall severity of IBS-C or CC, compared with placebo.
Keywords
CSBMNNTRCTBSFSFDAIBS-CTEAERandomized controlled trialClinical trialsITTRelative risktreatment emergent adverse eventFood and Drug Administrationirritable bowel syndrome with constipationnumber needed to treatconfidence intervalintention to treatSystematic reviewBristol Stool Form Scalecomplete spontaneous bowel movementColonChronic constipation
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Elizabeth J. Videlock, Vivian Cheng, Filippo Cremonini,